CXCR4 antagonist identified for hepatocellular carcinoma
Apr 7, 2021 | 5:05 PM GMT
DISEASE CATEGORY: Cancer
INDICATION: Liver cancer
An oxopropylaminoacetic acid-based CXCR4 antagonist could treat hepatocellular carcinoma (HCC). The CXCR4 inhibitor, optimized from
